News
News
View details of OEI's Next Investment Meeting.
Success stories - view brief case studies of companies that have successfully raised funds through OEI.
Press releases and articles
ARTICLE – 01 September, 2009
Theryte raises funding through Co Investment Programme
OXFORD, UK – 1 September 2009. Theryte, a cancer drug discovery company with a potential ‘blockbuster’ completed its funding round today.
Theryte requires working capital of £250k for a nine month programme to enable it to demonstrate proof of concept. Theryte secured their funding after a successful pitch at an investment meeting run by Oxford Early Investments.